Gisela Paulsen - Aug 15, 2022 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
President & COO
Signature
/s/ Gisela Paulsen
Stock symbol
OCX
Transactions as of
Aug 15, 2022
Transactions value $
$0
Form type
4
Date filed
8/17/2022, 08:22 PM
Previous filing
Mar 17, 2022
Next filing
Dec 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock, no par value Award $0 +175K +1060.61% $0.00 192K Aug 15, 2022 Direct F1
transaction OCX Common Stock, no par value Award $0 +350K +182.77% $0.00 542K Aug 15, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service from the date of grant until the vesting date.
F2 The Restricted Stock Units shall vest on January 1, 2024 based on the achievement of a pre-determined financial objective related to the Issuer's available cash.